News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interpharm Holdings, Inc. (IPA) Announces Revenue And Earnings For The Three And Nine - Month Periods Ended March 31, 2005


10/19/2005 5:10:03 PM

HAUPPAUGE, N.Y.--(BUSINESS WIRE)--May 17, 2005--Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical drugs, today announced its financial results for the three and nine month periods ended March 31, 2005. Net revenue for the three months was $10,670,000, which was $638,000 or 5.6% lower than the same period last year. The net decrease is primarily attributable to a decrease in net sales of Naproxen. Total revenue for the nine-month period ended March 31, 2005 was $28,561,000, a decrease of $1,329,000 or 4.4% from the same nine-month period a year ago. During this three-month period the Company's gross profit percentage decreased 3.6 percentage points to 21.3% compared to 24.9% for the three-month period ended March 31, 2004. This decrease is primarily the result of higher labor and insurance costs.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES